Pharm Exec Podcast
1) Pharmaceutical Executive Daily: President Trump's Great Healthcare Plan
In today’s Pharmaceutical Executive Daily, Johnson & Johnson announces plans for a second $2 billion manufacturing facility in North Carolina, President Trump calls on Congress to enact a sweeping hea...Show More
2) Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
In today’s Pharmaceutical Executive Daily we will focus on the 44th Annual J.P. Morgan Healthcare Conference, with Genmab outlining a disciplined strategy focused on sustained growth over the next dec...Show More
3) Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
In today’s Pharmaceutical Executive Daily we will focus on the 44th Annual J.P. Morgan Healthcare Conference, with Biogen outlining how a more focused company is emerging following years of transforma...Show More
4) Pharmaceutical Executive Daily: Johnson & Johnson Continues $55 Billion Manufacturing Investment
In today’s Pharmaceutical Executive Daily, Johnson & Johnson reaches an agreement with the Trump administration while continuing its $55 billion U.S. investment plan, Bristol Myers Squibb outlines its...Show More
5) Pharmaceutical Executive Daily: FDA Limits Regulations of Non-Medical Fitness Devices
In today’s Pharmaceutical Executive Daily, the FDA moves to limit regulation of non-medical fitness wearables, industry leaders examine how humans and AI can jointly create value in pharma, and Eli Li...Show More
6) Pharmaceutical Executive Daily: Amgen Acquires Dark Blue Therapeutics for $840 Million
In today’s Pharmaceutical Executive Daily, Amgen announces an $840 million acquisition of Dark Blue Therapeutics, GSK enters a multi-year precision medicine collaboration with Helix, and industry lead...Show More
7) Pharmaceutical Executive Daily: Alnylam Invests $250 Million in Manufacturing Facility
In today’s Pharmaceutical Executive Daily, Eli Lilly and Nimbus Therapeutics announce a major licensing deal for oral obesity treatments, Hoth Therapeutics expands its intellectual property portfolio ...Show More
8) Pharmaceutical Executive Daily: Wegovy Pill Becomes Available
In today’s Pharmaceutical Executive Daily, the Wegovy Pill becomes the first available oral GLP-1 for weight management, clears a new therapy to prevent motion-induced vomiting, and Sanofi enters a ne...Show More
9) Pharmaceutical Executive Daily: FDA Approves Wegovy Pill
In today’s Pharmaceutical Executive Daily, the FDA approves Novo Nordisk’s oral Wegovy for chronic weight management, clears Roche’s Lunsumio Velo for adults with relapsed or refractory follicular lym...Show More
10) Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
In today’s Pharmaceutical Executive Daily, President Trump announces nine additional participants in the TrumpRx program, AstraZeneca reaches a $2 billion licensing agreement with Jacobio Pharma for a...Show More